Skip to main content
Premium Trial:

Request an Annual Quote

Ventana, Bayer Reach CDx Development Deal

NEW YORK (GenomeWeb News) – Ventana Medical Systems today announced a collaboration with Bayer Pharma to develop a molecular companion diagnostic for a novel Bayer antibody-drug conjugate (ADC).

Ventana will use its immunohistochemistry platform to analyze the expression levels of certain tumor targets in clinical studies for patient selection in support of new therapy development efforts at Bayer, Ventana said. Ventana will initially develop, manufacture, and commercialize a companion diagnostic for a Bayer ADC.

During a five-year period, the two companies may also initiate additional projects to develop molecular companion diagnostics for other targeted cancer drugs.

Financial terms of the deal were not disclosed.

ADCs comprise of an antibody, a cytotoxic drug, and a linker. By targeting a drug selectively to tumor tissue, they improve a drug's efficacy while limiting its system toxicity, Ventana said.

The deal is the third by Ventana in recent weeks in the area of companion diagnostics. Last week, the company, part of the Roche Group, inked a pact with Pfizer to develop a companion diagnostic for a new Pfizer non-small cell lung cancer drug. Earlier in the month, it and Syndax Pharmaceuticals announced a deal for a companion diagnostic, also for a NSCLC drug in development.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.